In this study, we have found that high expression of VSTM2L could be significantly identified to predict poor tumor response and survival prognosis of rectal cancer patients receiving pCRT and described its important functional roles and potential mechanism of VSTM2L in rectal cancer with CRT based on the experimental evidences of patient-derived tumor organoid model and cell line. The gene discussed is VSTM2L; the disease is neoplasm.